Canadian evidence-based guideline for the first-line treatment of chronic lymphocytic leukemia

Carolyn Owen, A. S. Gerrie, V. Banerji, S. Assouline, C. Chen, K. S. Robinson, E. Lye, G. Fraser

Résultat de recherche: Articleexamen par les pairs

8 Citations (Scopus)

Résumé

Chronic lymphocytic leukemia (cll) is the most common adult leukemia in North America. In Canada, no unified national guideline exists for the front-line treatment of cll; provincial guidelines vary and are largely based on funding. A group of clinical experts from across Canada developed a national evidence-based treatment guideline to provide health care professionals with clear guidance on the first-line management of cll. Consensus recommendations based on available evidence are presented for the first-line treatment of cll.

Langue d'origineEnglish
Pages (de-à)e461-e474
JournalCurrent Oncology
Volume25
Numéro de publication5
DOI
Statut de publicationPublished - oct. 2018
Publié à l'externeOui

Note bibliographique

Publisher Copyright:
© 2018 Multimed Inc.

ASJC Scopus Subject Areas

  • Oncology

Empreinte numérique

Plonger dans les sujets de recherche 'Canadian evidence-based guideline for the first-line treatment of chronic lymphocytic leukemia'. Ensemble, ils forment une empreinte numérique unique.

Citer